Cyclerion Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Cyclerion Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2018 to Q3 2024.
  • Cyclerion Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 2.53M shares, a 3.51% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 2.53M +85.8K +3.51% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 2.52M +108K +4.49% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 2.5M -41M -94.3% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 2.47M +298K +13.7% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 2.45M -41M -94.4% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 2.41M -41.1M -94.5% Jun 30, 2023 10-Q 2023-07-28
Q1 2023 43.5M +76.5K +0.18% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 2.18M -41.2M -95% Dec 31, 2022 10-K 2024-03-05
Q3 2022 43.5M +184K +0.43% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 43.5M +205K +0.47% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 43.4M +9.32M +27.3% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 43.4M +9.36M +27.5% Dec 31, 2021 10-K 2023-03-22
Q3 2021 43.3M +9.35M +27.5% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 43.3M +15.4M +55.3% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 34.1M +6.38M +23% Mar 31, 2021 10-Q 2021-04-30
Q4 2020 34M +6.45M +23.4% Dec 31, 2020 10-Q 2021-11-09
Q3 2020 34M +6.49M +23.6% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 27.9M +447K +1.63% Jun 30, 2020 10-Q 2020-08-03
Q1 2020 27.8M +27.8M Mar 31, 2020 10-Q 2020-05-04
Q4 2019 27.6M +27.6M Dec 31, 2019 10-K 2021-02-25
Q3 2019 27.5M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 27.4M Jun 30, 2019 10-Q 2019-08-12
Q1 2019 0 Mar 31, 2019 10-Q 2020-08-03
Q4 2018 0 Dec 31, 2018 10-K 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.